The effects of acyl chain length on the micelle properties of poly(ethylene oxide)-block-poly(N-hexylL-aspartamide)-acyl conjugates
暂无分享,去创建一个
[1] G. Kwon,et al. The effect of alkyl core structure on micellar properties of poly(ethylene oxide)-block-poly(L-aspartamide) derivatives. , 2001, Colloids and surfaces. B, Biointerfaces.
[2] Guojun Liu,et al. Poly(solketal methacrylate)-block-poly(2-cinnamoyloxyethyl methacrylate)-block-poly(allyl methacrylate): Synthesis and Micelle Formation , 2001 .
[3] G. Kwon,et al. Micelles of poly(ethylene oxide)-block-poly(N-alkyl stearate L-aspartamide): synthetic analogues of lipoproteins for drug delivery. , 2000, Journal of biomedical materials research.
[4] Glen S. Kwon,et al. Methotrexate Esters of Poly(Ethylene Oxide)-Block-Poly(2-Hydroxyethyl-L-Aspartamide). Part I: Effects of the Level of Methotrexate Conjugation on the Stability of Micelles and on Drug Release , 2000, Pharmaceutical Research.
[5] Y. M. Lee,et al. Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide)/poly(epsilon-caprolactone) (PCL) amphiphilic block copolymeric nanospheres. II. Thermo-responsive drug release behaviors. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[6] Y. Nagasaki,et al. Preparation and characterization of polymer micelles from poly(ethylene glycol)-poly(D,L-lactide) block copolymers as potential drug carrier. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[7] Christine Allen,et al. Nano-engineering block copolymer aggregates for drug delivery , 1999 .
[8] G. Kwon,et al. Micelle-like structures of poly(ethylene oxide)-block-poly(2-hydroxyethyl aspartamide)-methotrexate conjugates , 1999 .
[9] T. Okano,et al. Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[10] T. Okano,et al. Polymeric micelles for drug delivery: solubilization and haemolytic activity of amphotericin B. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[11] A. Eisenberg,et al. Morphogenic Effect of Solvent on Crew-Cut Aggregates of Apmphiphilic Diblock Copolymers , 1998 .
[12] F. Winnik,et al. Fluorescence methods in the study of the interactions of surfactants with polymers , 1996 .
[13] Markus Antonietti,et al. Micellization of strongly segregated block copolymers , 1996 .
[14] Leaf Huang,et al. Effects of Polyethyleneglycol Chain Length and Phospholipid Acyl Chain Composition on the Interaction of Polyethyleneglycol-phospholipid Conjugates with Phospholipid: Implications in Liposomal Drug Delivery , 1996, Pharmaceutical Research.
[15] P. Wisian-Neilson,et al. Modification of poly(methylphenylphosphazene) to increase hydrophobicity , 1994 .
[16] Teruo Okano,et al. Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer-Adriamycin conjugates , 1994 .
[17] T. Okano,et al. Micelles based on AB block copolymers of poly(ethylene oxide) and poly(.beta.-benzyl L-aspartate) , 1993 .
[18] T. Okano,et al. Preparation of micelle-forming polymer-drug conjugates. , 1992, Bioconjugate chemistry.
[19] T. A. Hatton,et al. Solubilization of polycyclic aromatic hydrocarbons by poly(ethylene oxide-propylene oxide) block copolymer micelles: effects of polymer structure , 1992 .
[20] M. Winnik,et al. The Py scale of solvent polarities , 1984 .
[21] D. Georgescauld,et al. INTRAMOLECULAR EXCIMER FLUORESCENCE: A NEW PROBE OF PHASE TRANSITIONS IN SYNTHETIC PHOSPHOLIPID MEMBRANES , 1980 .
[22] J. K. Thomas,et al. Environmental effects on vibronic band intensities in pyrene monomer fluorescence and their application in studies of micellar systems , 1977 .
[23] Teruo Okano,et al. Preparation and Characterization of the Micelle-Forming Polymeric Drug Indomethacin-lncorporated Polyfethylene oxide)-Poly(β-benzyl L-aspartate) Block Copolymer Micelles , 1996 .